Welcome to medications.com

Topamax Information

What's inside Topamax

Topamax Active Ingredients: topiramate, details.
Topamax Dosages & Strengths
Strength Format Route Strength Class
Topamax 25 mg tablet oral 1.0 each OTC
Topamax 100 mg tablet oral 1.0 each OTC
Topamax 200 mg tablet oral 1.0 each OTC
Topamax 50 mg tablet oral 1.0 each OTC

Recent Topamax Side Effects

Posted by aleancol 1 day ago
In August I started taking Topamax and every week i am to up the dosage now I am taking 50mg in the morning and and 50 mg at ...

Posted by kfgmorris 4 days ago
Ive been on Topamax for almost 3 years. Was on 100 mg/day for 1 1/2 yrs. Couldn't take the spaciness so I went off of it. A n...

Posted by lin06 5 days ago
At 50mg a day, Topamax, taken at night, makes me feel very heavy, tired and numb all day. I have been on it for 3 months so ...


Topamax in the News

Study Finds IONSYS™, A New Needle-Free System For Management Of ... - Medical News Today (press release)
... CONCERTA® (ADHD), EPREX® (anaemia), SPORANOX® (fungal infections), VELCADE® (multiple myeloma), PARIET® (gastroenterology), TOPAMAX® (epilepsy), ...
Mon Mar 10 03:09:06 -0400 2008

Study finds IONSYS (TM), a New Needle-Free System for Management ... - PR Newswire UK (press release)
... SPORANOX(R) (fungal infections), VELCADE(R) (multiple myeloma), PARIET(R) (gastroenterology), TOPAMAX(R) (epilepsy), REMINYL(R) (Alzheimer's disease), ...
Tue Mar 04 01:06:57 -0500 2008

Benefiting From 2008's Generic Drugs - Motley Fool
Other blockbusters losing their patent protection in 2008 include Johnson & Johnson's (NYSE: JNJ) Topamax, which Barr Labs and Mylan (NYSE: MYL) are set to ...
Thu Feb 28 14:45:19 -0500 2008


Topamax Chemical Information

topiramate - A sulfamate-substituted monosaccharide with anticonvulsant property. Although the mechanism of action has not been fully elucidated, topiramate antagonizes kainate/AMPA subtype of the glutamate receptors, which are ligand-activated cation channels that mediate the fast component of excitatory postsynaptic currents in neurons of the central nervous system. This antagonistic action results in stabilizing hyper-excited neural membranes, inhibiting repetitive neuronal firing, and decreasing propagation of synaptic impulses, thereby impedes seizure occurrences. In addition, this agent augments gamma-aminobenzoic acid (GABA) activity and thereby attenuating GABAnergic inhibitory transmission.




ADVERTISEMENT
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com